EP Patent

EP1568706A1 — Novel steroid agonist for FXR

Assigned to Intercept Pharmaceuticals Inc · Expires 2005-08-31 · 21y expired

What this patent protects

The invention relates to a FXR agonist of formula (I):    and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof.

USPTO Abstract

The invention relates to a FXR agonist of formula (I):    and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP1568706A1
Jurisdiction
EP
Classification
—
Expires
2005-08-31
Drug substance claim
No
Drug product claim
No
Assignee
Intercept Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.